TNGX compared with SYRE: revenue, margins and what each company keeps, and the suppliers and customers both name

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TNGXTango Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

TNGXwithSYRE

Uncorrelated: r 0.23 · 500D.

Shared co-movers2with TNGXwith SYRE

IDYAIDEAYA Biosciences, Inc.r 0.33r 0.47

NRIXNurix Therapeutics, Inc.r 0.28r 0.46

TNGX, solidSYRE, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

TNGXTango Therapeutics, Inc.

21.75▼−4.25%· post 21.75

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

SYRESpyre Therapeutics, Inc.

95.54▼−1.05%· post 95.54

ClosedNov 2 '26

Mkt cap$8.4BRevenue—Revenue—

Compare

ClosedNov 2 '26

TNGXTango Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

21.75▼−4.25%post 21.75

Price

95.54▼−1.05%post 95.54

$3.8B

Mkt cap

$8.4B

Q3 FY25$54M

Revenue

—

FY24$42M

Revenue

—

TNGX21.75▼−4.25%vsSYRE95.54▼−1.05%ClosedNov 2 '26